| Cas No.: | 250694-07-6 |
| 名称: | (3R)-3-(tetradecylcarbamoylamino)-4-(trimethylazaniumyl)butanoate |
| 别名: | Teglicar, 250694-07-6, UNII-8V3VQ6HMII, 4-trimethylammonio-TDCAB, CHEMBL1231506, CHEBI:41251, SPB-80348, KB-80830 |
| SMILES: | O=C(N[C@H](CC([O-])=O)C[N+](C)(C)C)NCCCCCCCCCCCCCC |
| 分子式: | C22H45N3O3 |
| 分子量: | 399.611 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | Teglicar, in vitro and in animal models, reduces gluconeogenesis and improves glucose homeostasis, refreshing the interest in selective and reversible L-CPT1 inhibition as a potential antihyperglycemic approach.For the detailed information of Teglicar, th |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
